Healthcare remains one of the most exciting and dynamic sectors in the entire market.
Demand remains steady and, thanks to plenty of innovation, lifespans continue to grow. That, in turn, is driving more demand for healthcare solutions. Perhaps the most exciting sub-segment of the healthcare industry is biotech stocks.
But for many investors, biotech still represents a “lotto ticket” proposition. The sector is littered with failures, missed opportunities and evaporating capital. To that end, most conservative investors take a pass on the sector.
However, that could be a poor decision.
The reality is, many of the top biotech stocks are dividend machines – pumping out billions in cash flows and sales from blockbuster drugs. For investors, these dynamic firms offer a great combination of growth and income.
Read more about why you need to think about healthcare costs.